Drawing for MYMEDS&ME

USPTO serial 79138122

MYMEDS&ME

Reviewed by CopyMark Law Group

Reg. 4607742Status 709
Filing date
Status date
Registration date
Sep 23, 2014
Examiner
SOBRAL, CHRISTINA
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MYMEDS&ME?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Cynthia A. Moyer

Cynthia A. Moyer Fredrikson & Byron, P.A.60 South Sixth StreetSuite 1500Minneapolis, MN 55402

Goods and services

ClassDescriptionStatusFirst use
009computer software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of data and information concerning the quality, safety and effectiveness of medications and/or pharmaceuticals and reactions and events resulting from the use of medications and/or pharmaceuticals; computer software for capturing and providing information concerning quality of medication and/or pharmaceuticals and reactions and events resulting from the use of medication and/or pharmaceuticals, enabling follow-up questions and answers regarding said quality, reactions and events and producing reports regarding such quality, reactions and events; computer programs for capturing and providing information concerning the quality of medication and/or pharmaceuticals and reactions and events resulting from the use of medication and pharmaceuticals, for enabling follow-up questions and answers regarding said quality, reactions and events and for producing reports regarding such quality, reactions and events; computer software applications for capturing information concerning the quality of medication and/or pharmaceuticals, reactions and events resulting from the use of medication and pharmaceuticals, for enabling follow-up questions and answers regarding said reactions and events and for producing reports regarding such quality, reactions and events; computer software for the evaluation and analysis of data and information concerning the quality, safety and effectiveness of medication and/or pharmaceuticals and the reactions and events resulting from the use of medication and/or pharmaceuticalsSECTION 71 - CANCELLED—
038Telecommunications services, namely, transmission of data by means of telecommunications networks, wireless communication networks and the Internet; telecommunication services for providing multiple user access to a global network; transfer of data by telecommunication; transmission and reception of database information via telecommunications networks; data transmission and reception services via telecommunications means; providing telecommunications connections to databases; electronic exchange of data stored in databases accessible via telecommunication networks; communication services, namely, providing electronic transmission of information stored in a database via interactively communicating computer systems; providing multiple use access to global computer information networks for the transfer and dissemination of a wide range of information; information transmission via electronic communications networks; providing multiple user access to proprietary collections of information by means of global computer information networks; telecommunication services, namely, electronic exchange of medical records between patients or health care professionals and pharmaceutical companies; telecommunication services, namely, providing access to an electronic exchange of medical records between patients or health care professionals and pharmaceutical companiesSECTION 71 - CANCELLED—
042software as a service (SAAS) services featuring software for capturing and providing data concerning the quality of medication and/or pharmaceuticals, reactions and events resulting from the use of medication and/or pharmaceuticals, for enabling follow up questions and answers regarding said reactions and events and for producing reports regarding such quality, reactions and events; software as a service (SAAS) services featuring software for evaluating and analysing data and information concerning the quality of medication and/or pharmaceuticals and the reactions and events resulting from the use of medication or pharmaceuticals; providing temporary use of on-line non-downloadable software which enables the capture of information concerning the quality of medication and/or pharmaceuticals, reactions and events resulting from the use medication and/or pharmaceuticals, as well as enabling followup questions and answers regarding said quality, reactions and events and enables the production of reports regarding said reactions and events; services for maintenance of computer software; providing temporary use of non-downloadable software allowing web site users to send and receive information concerning the quality of medication and/or pharmaceuticals used, reactions and events resulting from the use of medication and/or pharmaceuticals, answer (and read answers to) follow-up questions regarding said quality, reactions and events and produce reports regarding said reactions and events; software as a service (SAAS) services featuring software for collecting, evaluating and analysing data concerning the quality of medication and/or pharmaceuticals used, reactions and events resulting from the use of medication and/or pharmaceuticalsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 6, 2026INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Mar 6, 2026C71TCANCELLED SECTION 71—
Sep 23, 2023REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Aug 21, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 21, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 21, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 3, 2023RNWLINTERNATIONAL REGISTRATION RENEWED—
May 12, 2021NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
May 12, 2021C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Jan 5, 2021APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 23, 2020ES75TEAS SECTION 71 & 15 RECEIVED—
Mar 13, 2015FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 26, 2015FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 26, 2015FIMPFINAL DISPOSITION PROCESSED—
Dec 23, 2014FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 23, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 22, 2014GPNXNOTIFICATION PROCESSED BY IB—
Jul 8, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 2, 2014OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 2, 2014OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jun 18, 2014NPUBNOTICE OF PUBLICATION—
May 31, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 31, 2014ALIEASSIGNED TO LIE—
May 19, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 16, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 15, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 15, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 10, 2013RFNTREFUSAL PROCESSED BY IB—
Nov 19, 2013MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 15, 2013RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 14, 2013RFRRREFUSAL PROCESSED BY MPU—
Nov 14, 2013RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 13, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 13, 2013DOCKASSIGNED TO EXAMINER—
Nov 13, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 12, 2013LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Nov 11, 2013REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance